Osenvelt 120 mg/1.7 ml (70 mg/ml), solution injectable

( ARTG ) - Prevention of skeletal related events in patients with multiple myeloma and in patients with bone metastases from solid tumours. ,- Treatment of giant cell tumour of bone in adults or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity. ,- Treatment of hypercalcaemia of malignancy that is refractory to intravenous bisphosphonate.